Virtual Medicinal Product (VMP) - Haloperidol decanoate 50mg/1ml solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Haloperidol decanoate 50mg/1ml solution for injection ampoules Start Date 26-05-2004 End Date
Previous Name Previous Name Haloperidol decanoate 50mg/ml injection 1ml ampoules Start Date 29-01-2003 End Date 25-05-2004
Abbreviated Name Abbreviated Name Haloperidol decanoate 50mg/1ml inj ampoules Start Date 01-05-2009
Previous Abbreviated Name Haloperidol decanoate 50mg/1ml soln for inj ampoules Previous Start Date 12-09-2005 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Solution for injection
Ontology Form/Route
solutioninjection.intramuscular
Name Basis
INNM - International Non-proprietary Name (Modified)

Codes

ATC Code
N05AD01
BNF Start Date End Date
Current BNF 04020200 Start Date 04-04-2022 End Date
Previous BNF 04020100 Start Date 02-02-2005 End Date 03-04-2022
Previous BNF 04020200 Start Date 02-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36053711000001104 29-10-2018
321700008 29-01-2003 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Haloperidol decanoate Based on Base Substance Haloperidol 50 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
5 ampoule 1906 Part VIIIA Category C